Cancer Suppression at Old Age
Open Access
- 1 June 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 68 (11), 4465-4478
- https://doi.org/10.1158/0008-5472.can-07-1670
Abstract
Increased age is regularly linked with heightened cancer risk, but recent research suggests a flattening around age 80. We report that, independent of cancer site or time period, most incidence rates decrease in the more elderly and drop to or toward zero near the ceiling of human life span. For all major organ sites, male and female, we use 1979 to 2003 Surveillance, Epidemiology, and End Results registry records (8–26% of the U.S. population) to construct three sequential cross-sections at 10-year intervals, totaling 129 sets of age-specific cancer data. To compute incidence rates, we estimate older populations at risk with census counts and NIH life tables. This article provides both a minimal and a more comprehensive extension of Surveillance, Epidemiology, and End Results cancer rates to those above 85. Almost all cancers peak at age ∼80. Generally, it seems that centenarians are asymptomatic or untargeted by cancers. We suggest that the best available justification for this pattern of incidence is a link between increased senescence and decreased proliferative potential among cancers. Then, thus far, as senescence may be a carcinogen, it might also be considered an anticarcinogen in the elderly. We model rising and falling incidence rates with a β curve obtained by appending a linearly decreasing factor to the well-known Armitage-Doll multistage model of cancer. Taken at face value, the β model implies that medical, diet, or lifestyle interventions restricting carcinogenesis ought to be examined for possible effects on longevity. [Cancer Res 2008;68(11):4465–78]This publication has 25 references indexed in Scilit:
- Nutrient-Sensitive Mitochondrial NAD+ Levels Dictate Cell SurvivalCell, 2007
- Frailty modelling of colorectal cancer incidence in Norway: Indications that individual heterogeneity in risk is related to birth cohortEuropean Journal of Epidemiology, 2006
- Making Young Tumors Old: A New Weapon Against Cancer?Science of Aging Knowledge Environment, 2005
- Commentary: The age distribution of cancer and a multistage theory of carcinogenesis.International Journal of Epidemiology, 2004
- The Decline of the Clinical Incidence of Cancers during Human SenescenceGerontology, 2003
- Overview of the SEER-Medicare DataMedical Care, 2002
- p53 mutant mice that display early ageing-associated phenotypesNature, 2002
- Clinicopathological analysis on cancers of autopsy cases in a geriatric hospitalPathology International, 1997
- Clinical and post‐mortem assessment of the cause of deathThe Journal of Pathology, 1977
- A mathematical model for the age distribution of cancer in manInternational Journal of Cancer, 1969